298040:KRXHyosung Heavy Industries Corp. Analysis
Data as of 2026-03-14 - not real-time
₩2,593,000.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hyosung Heavy Industries is trading well above its 20‑day and 50‑day simple moving averages, indicating strong short‑term momentum, while the RSI sits near the midpoint of its range, suggesting no immediate overbought pressure. Technical momentum remains bullish despite a bearish MACD histogram, which warns of a possible near‑term correction. Volume has been stable, supporting the price move without signs of thin trading. The stock’s forward P/E of roughly 23 is comfortably below the industry average of 29, pointing to a valuation edge. Dividend sustainability looks solid with a low payout ratio and ample cash on hand. Overall, the technical picture is mixed but leans positive, setting the stage for a cautious short‑term stance.
Fundamentally, the company posted a 42% year‑over‑year revenue surge and maintains a healthy ROE above 20%, underscoring robust growth fundamentals. Debt levels are moderate, with a debt‑to‑equity ratio under 50%, and free cash flow remains strong, providing a cushion for dividend payments and reinvestment. The firm’s exposure to renewable‑energy solutions and global export markets adds a strategic growth tailwind. Volatility is elevated at over 80% on a 30‑day basis, yet the beta below one suggests market‑wide shocks may be muted. Given these dynamics, the stock appears undervalued relative to peers and offers an attractive risk‑adjusted profile for medium to long‑term investors.
Fundamentally, the company posted a 42% year‑over‑year revenue surge and maintains a healthy ROE above 20%, underscoring robust growth fundamentals. Debt levels are moderate, with a debt‑to‑equity ratio under 50%, and free cash flow remains strong, providing a cushion for dividend payments and reinvestment. The firm’s exposure to renewable‑energy solutions and global export markets adds a strategic growth tailwind. Volatility is elevated at over 80% on a 30‑day basis, yet the beta below one suggests market‑wide shocks may be muted. Given these dynamics, the stock appears undervalued relative to peers and offers an attractive risk‑adjusted profile for medium to long‑term investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages shows momentum
- Bearish MACD histogram signals potential pullback
- Elevated short‑term volatility warrants caution
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and ROE
- Forward P/E advantage versus industry
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic positioning in renewable‑energy and export markets
- Solid balance sheet with ample cash and manageable debt
- Undervalued relative to peers offering upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth41.80%
Profit Margin7.52%
P/E Ratio22.8
ROE24.01%
ROA5.67%
Debt/Equity47.08
Op. Cash Flow₩515.4B
Free Cash Flow₩242.3B
Industry P/E29.1
Technical Analysis
TrendBullish
RSI54.6
Support₩2,220,000.00
Resistance₩2,941,000.00
MA 20₩2,555,000.00
MA 50₩2,329,320.00
MA 200₩1,605,045.00
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
Fair Value₩898,834.46
Target Price₩3,215,625.00
Upside/Downside24.01%
GradeUndervalued
TypeGrowth
Dividend Yield0.29%
Risk Assessment
Beta0.90
Volatility82.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.